Innate Pharma SA announced that it has obtained €28.7 Million in non-dilutive financing in the form of two loans from Société Générale and BNP Paribas. The two loans have an initial term of one year with a five-year extension option. They are 90% guaranteed by the French state as part of the package of measures put in place by the French government to support companies during the COVID-19 pandemic.